Thermo Fisher Scientific Treasury Stock decreased by 0.0% to $22.31B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.0%, from $19.23B to $22.31B. Over 5 years (FY 2020 to FY 2025), Treasury Stock shows an upward trend with a 26.8% CAGR.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.86B | $8.91B | $8.92B | $10.96B | $10.96B | $11.01B | $12.02B | $15.08B | $15.08B | $15.12B | $15.13B | $18.19B | $18.19B | $18.23B | $19.23B | $21.27B | $21.27B | $22.31B | $22.31B |
| QoQ Change | — | +0.6% | +0.1% | +22.9% | +0.0% | +0.4% | +9.1% | +25.5% | +0.0% | +0.2% | +0.1% | +20.2% | +0.0% | +0.2% | +5.5% | +10.6% | +0.0% | +4.9% | -0.0% |
| YoY Change | — | — | — | — | +23.8% | +23.6% | +34.7% | +37.6% | +37.6% | +37.3% | +25.9% | +20.6% | +20.6% | +20.5% | +27.0% | +17.0% | +16.9% | +22.4% | +16.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.